Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Nariman Nezami

Vascular & Interventional Radiology Baltimore, MD Medical Doctor

NPI 1619381506 CMS profile 8049881

22 S Greene St, Dept Of Radiology, Baltimore, MD 21201

Open in the dashboard

General payments

$411,679

413 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$204,712 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Nariman Nezami of Baltimore, MD is reported in the CMS Open Payments database as having received $411,679 across 413 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $204,712 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $273,301 157
2024 General $123,817 130
2023 General $8,629 68
2022 General $2,729 29
2021 General $2,708 22
2020 General $495 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nariman Nezami
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nariman Nezami were reported at $273,301. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nariman Nezami Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $495 $200 $68–$652 $114
2021 $2,708 $280 $99–$866 $132
2022 $2,729 $433 $137–$1,497 $149
2023 $8,629 $506 $152–$2,019 $160
2024 $123,817 $556 $175–$1,930 $164
2025 $273,301 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Boston Scientific Corporation $389,545 292 payments
  2. Medtronic, Inc. $6,884 27 payments
  3. Surefire Medical, Inc. $4,880 14 payments
  4. Guerbet LLC $3,150 9 payments
  5. AngioDynamics, Inc. $1,544 9 payments
  6. Penumbra, Inc. $749 8 payments
  7. Provepharm Inc. $700 1 payment
  8. Abbott Laboratories $624 6 payments
  9. Stryker Corporation $483 5 payments
  10. Bard Peripheral Vascular, Inc. $467 4 payments
  11. Other $2,654 38 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $338,375 74 payments
  2. Travel and Lodging $41,822 117 payments
  3. Food and Beverage $19,432 215 payments
  4. Consulting Fee $8,706 4 payments
  5. Honoraria $3,000 1 payment
  6. Grant $268 1 payment
  7. Gift $75 1 payment
Products named General payments · program years 2020–2025
  1. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $278,178 113 payments
  2. General - Embolics $50,104 32 payments
  3. General - Therapies $8,012 10 payments
  4. TheraSphere Y90 Glass Microspheres 10 GBq $6,185 34 payments
  5. TRINAV INFUSION SYSTEM $4,880 14 payments
  6. KYPHON EXPRESS II KYPHOPAK TRAY $4,665 2 payments
  7. Lipiodol $3,150 9 payments
  8. General - IO Ablation $2,841 3 payments
  9. OBSIDIO $1,569 10 payments
  10. Ellipsys $1,568 9 payments
  11. Other $9,909 147 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 127 billing codes

Paid by Medicare

$68,440

Medicare's payments for the services billed

Medicare patients

217

Average age 69

Services billed

821

107 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Diabetes 44%
Chronic kidney disease 41%
Ischemic heart disease 40%
Cancer 34%
Heart failure 25%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

413 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record